| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Shoulder Innovations, Inc.
13D/A
SI · 82537J108
|
10.7% |
8/7/2026
Event 8/5/2026
|
||||
| Gilde Healthcare Holding B.V. | 10.7% | |||||
| Gilde Healthcare V Management B.V. | 10.7% | |||||
| Cooperatieve Gilde Healthcare V U.A. | 10.7% | |||||
| Manapouri B.V. | 10.7% | |||||
| Martemanshurk B.V. | 10.7% | |||||
|
SpyGlass Pharma, Inc.
13D
SGP · 85220G109
|
6.6% |
2/13/2026
Event 2/9/2026
|
||||
| Gilde Healthcare Holding B.V. | 6.6% | |||||
| Gilde Healthcare VG VI Management B.V. | 6.6% | |||||
| Cooperatieve Gilde Healthcare VG VI U.A. | 6.6% | |||||
| Manapouri B.V. | 6.6% | |||||
| Martemanshurk B.V. | 6.6% | |||||
| Schedule 13G · 1 security · passive | ||||||
|
Mobia Medical, Inc.
13G
MOBI · 60705V103
|
6.3% |
5/15/2026
Event 5/8/2026
|
||||
| Gilde Healthcare Holding B.V. | 6.3% | |||||
| Cooperatieve Gilde Healthcare VG VI U.A. | 6.3% | |||||
| Gilde Healthcare VI Management B.V. | 6.3% | |||||
| Manapouri B.V. (100% owned by Edwin de Graaf | 6.3% | |||||
| Martemanshurk B.V. (100% owned by Pieter van der Meer) | 6.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.